EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Precision Nodal Staging in Intermediate-Risk Prostate Cancer: A Narrative Review of Molecular Imaging

Banchao Shen, Fuli Wang

Urologia Internationalis · 12.06.2026 · 1-13

DOI: 10.1159/000552660 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Urologia Internationalis, online erschienen am 12.06.2026. Verfasst von Banchao Shen und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Xijing Hospital, Air Force Medical University, Xi'an, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 72 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background: Lymph node (LN) staging remains critical for risk stratification and treatment selection in intermediate-risk prostate cancer (IR-PCa). Conventional imaging modalities have limited sensitivity, and extended pelvic LN dissection (ePLND) is associated with considerable morbidity. Summary: This narrative review evaluates conventional imaging, molecular imaging, and intraoperative technologies for LN staging in IR-PCa. Conventional computed tomography and magnetic resonance imaging demonstrate low sensitivity for detecting LN metastasis. Prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography shows substantially improved diagnostic performance; however, it may still underestimate micrometastatic disease. Intraoperative approaches, including PSMA-targeted fluorescence imaging and sentinel LN biopsy, enable real-time detection and may reduce morbidity while maintaining high diagnostic accuracy in experienced centers. However, these techniques are limited by technical complexity, lack of standardized protocols, and restricted availability in routine clinical practice. Key Messages: A multimodal, risk-adapted strategy combining preoperative molecular imaging and intraoperative targeted techniques may improve the precision of LN staging. This integrated approach can help minimize unnecessary ePLND and reduce procedure-related morbidity in patients with IR-PCa.

Schlagwörter

Stichwörter der Autor:innen

Lymph node stagingMolecular imagingProstate cancerProstate-specific membrane antigen positron emission tomography/computed tomogr…Sentinel lymph node biopsy

Autor:innen und Institutionen

  • Department of Urology, Xijing Hospital, Air Force Medical University, Xi'an, China.
  • Department of Urology, No.988 Hospital of Joint Logistic Support Force, Zhengzhou, China.
  • Department of Urology, Xijing Hospital, Air Force Medical University, Xi'an, China, wangfuli98@163.com.

Zitieren

APA

Shen, B., & Wang, F. (2026). Precision Nodal Staging in Intermediate-Risk Prostate Cancer: A Narrative Review of Molecular Imaging. Urologia Internationalis, 1-13. https://doi.org/10.1159/000552660

Vancouver

Shen B, Wang F. Precision Nodal Staging in Intermediate-Risk Prostate Cancer: A Narrative Review of Molecular Imaging. Urologia Internationalis. 2026:1-13. doi:10.1159/000552660

BibTeX
@article{Shen2026,
  author = {Shen, Banchao and Wang, Fuli},
  title = {Precision Nodal Staging in Intermediate-Risk Prostate Cancer: A Narrative Review of Molecular Imaging},
  journal = {Urologia Internationalis},
  year = {2026},
  pages = {1--13},
  doi = {10.1159/000552660}
}
Kostenlos starten →